Analyst Consensus ?
ConsensusHold29 ratings
Bullish1034.5%
Neutral1758.6%
Bearish26.9%
FN2 Earnings Intelligence
McCormick & Company, Incorporated analyst ratings
McCormick & Company, Incorporated (MKC) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$46.8Current
$47Low
$67.94Average
$93High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Oct 2, 2026 |
| TD Cowen | Hold | Hold | Maintain | Oct 2, 2026 |
| Stifel | Hold | Hold | Maintain | Oct 2, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Oct 2, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 2, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Sep 18, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Jun 26, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jun 26, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 1, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jun 17, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 2, 2024 |
| Argus Research | Buy | Hold | Upgrade | Apr 2, 2024 |
| Consumer Edge Research | Equal Weight | Overweight | Downgrade | Jan 22, 2024 |
| Exane BNP Paribas | Outperform | Outperform | Maintain | Nov 15, 2022 |
| Credit Suisse | Neutral | Outperform | Downgrade | Jan 19, 2022 |
| CFRA | Hold | Hold | Maintain | Mar 31, 2020 |
| Goldman Sachs | Sell | Neutral | Downgrade | Dec 10, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Sep 28, 2018 |
| Vertical Research | Hold | Buy | Downgrade | Jun 29, 2018 |
| Vertical Group | Hold | Buy | Downgrade | Jun 29, 2018 |
| Bank of America | Buy | Buy | Maintain | Dec 6, 2016 |
| BB&T Capital | Hold | Buy | Downgrade | Feb 18, 2016 |
| S&P Capital IQ | Sell | Hold | Downgrade | Jan 29, 2014 |
| Wellington Shields | Buy | Buy | Maintain | Sep 27, 2013 |
| Keybanc | Hold | Buy | Downgrade | Apr 22, 2013 |
| Northcoast Research | Neutral | Buy | Downgrade | Apr 1, 2013 |
| Davenport | Neutral | Buy | Downgrade | Jan 10, 2013 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Aug 3, 2012 |
| Janney Capital | Neutral | Buy | Downgrade | Aug 3, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $46.8. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $48 | $44.52 | +2.6% | Oct 2, 2026 |
| Deutsche Bank | Analyst unavailable | $57 | $44.55 | +21.8% | Oct 2, 2026 |
| Bernstein | Alexia Howard | $59 | $44.14 | +26.1% | Oct 2, 2026 |
| Stifel Nicolaus | Matthew Smith | $48 | $44.14 | +2.6% | Oct 2, 2026 |
| Barclays | Analyst unavailable | $47 | $44.14 | +0.4% | Oct 2, 2026 |
| Coker Palmer | Thomas Palmer | $62 | $49.34 | +32.5% | Sep 18, 2026 |
| Barclays | Analyst unavailable | $55 | $51.05 | +17.5% | Jun 29, 2026 |
| UBS | Analyst unavailable | $52 | $48.35 | +11.1% | Jun 26, 2026 |
| Bernstein | Alexia Howard | $68 | $48.35 | +45.3% | Jun 26, 2026 |
| Deutsche Bank | Analyst unavailable | $60 | $48.35 | +28.2% | Jun 26, 2026 |
| UBS | Peter Grom | $51 | $46.28 | +9.0% | Jun 2, 2026 |
| Barclays | Andrew Lazar | $67 | $60.79 | +43.2% | Jan 26, 2026 |
| UBS | Bryan Adams | $67 | $60.12 | +43.2% | Jan 23, 2026 |
| Bernstein | Analyst unavailable | $85 | $61.2 | +81.6% | Jan 23, 2026 |
| Coker Palmer | Thomas Palmer | $72 | $61.2 | +53.8% | Jan 23, 2026 |
| Deutsche Bank | Analyst unavailable | $75 | $66.8 | +60.3% | Dec 15, 2025 |
| Bernstein | Alexia Howard | $87 | $66.28 | +85.9% | Dec 11, 2025 |
| Jefferies | Analyst unavailable | $78 | $65.86 | +66.7% | Oct 8, 2025 |
| UBS | Analyst unavailable | $70 | $65.86 | +49.6% | Oct 8, 2025 |
| Bernstein | Alexia Howard | $93 | $65.62 | +98.7% | Oct 8, 2025 |
| Stifel Nicolaus | Analyst unavailable | $71 | $65.62 | +51.7% | Oct 8, 2025 |
| Deutsche Bank | Steve Powers | $71 | $65.62 | +51.7% | Oct 8, 2025 |
| Barclays | Andrew Lazar | $72 | $65.62 | +53.8% | Oct 8, 2025 |
| UBS | Bryan Adams | $71 | $67.16 | +51.7% | Oct 1, 2025 |
| Coker Palmer | Thomas Palmer | $82 | $65.71 | +75.2% | Sep 25, 2025 |
| UBS | Analyst unavailable | $79 | $72.26 | +68.8% | Aug 22, 2025 |
| Coker Palmer | Thomas Palmer | $77 | $72.96 | +64.5% | Jun 17, 2025 |
| Jefferies | Rob Dickerson | $91 | $77.5 | +94.4% | Dec 9, 2024 |
| Jefferies | Rob Dickerson | $85 | $78.86 | +81.6% | Oct 22, 2024 |
| Stifel Nicolaus | Matthew Smith | $85 | $84.09 | +81.6% | Oct 2, 2024 |
| Goldman Sachs | Adam Samuelson | $69 | $84.09 | +47.4% | Oct 1, 2024 |
| Jefferies | Rob Dickerson | $86 | $84.09 | +83.8% | Oct 1, 2024 |
| CFRA | Arun Sundaram | $93 | $82.92 | +98.7% | Oct 1, 2024 |
| Argus Research | John Staszak | $80 | $70.6 | +70.9% | Jun 28, 2024 |
| Deutsche Bank | Steve Powers | $73 | $70.6 | +56.0% | Jun 28, 2024 |
| Coker Palmer | Thomas Palmer | $69 | $69.2 | +47.4% | Jun 12, 2024 |
| Argus Research | John Staszak | $88 | $76.62 | +88.0% | Apr 2, 2024 |
| HSBC | Alejandro Zamacona | $79 | $76.6 | +68.8% | Mar 27, 2024 |
| Stifel Nicolaus | Matthew Smith | $75 | $76.37 | +60.3% | Mar 27, 2024 |
| CFRA | Arun Sundaram | $85 | $77.3 | +81.6% | Mar 26, 2024 |
| Deutsche Bank | Analyst unavailable | $83 | $84.18 | +77.4% | Dec 6, 2022 |
| Barclays | Analyst unavailable | $82 | $81.26 | +75.2% | Sep 12, 2022 |
| Deutsche Bank | Analyst unavailable | $79 | $78.38 | +68.8% | Sep 8, 2022 |
| Deutsche Bank | Steve Powers | $85 | $82.07 | +81.6% | Jul 9, 2022 |
| Deutsche Bank | Analyst unavailable | $91 | $83.01 | +94.4% | Jun 21, 2022 |
Track every rating change on MKC the moment it posts. Free to start.
Start freeGet the MKC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.